Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference
05. März 2024 08:45 ET
|
Accelus
Accelus CEO Kevin McGann to speak at LSI USA '24, showcasing its leading spinal implants and recent successes, including a $55M Remi sale and $20M funding.
Accelus Strengthens Leadership with New Board Appointments
12. Februar 2024 08:45 ET
|
Accelus
Accelus Adds President & CEO Kevin McGann and High-Performance Management Expert Bernie Haffey to the Company's Board of Directors.
Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology
07. Dezember 2023 08:23 ET
|
Accelus
Accelus announces a renewed focus on MIS with its innovative FlareHawk system for outpatient and awake lumbar fusion, aligning with 2024 trends.
UPDATE -- Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
18. Oktober 2022 07:38 ET
|
Accelus
PALM BEACH GARDENS, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
18. Oktober 2022 06:00 ET
|
Accelus
PALM BEACH GARDENS, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System
15. August 2022 08:59 ET
|
Accelus
New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., Aug. 15, 2022 ...
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
19. Mai 2022 08:35 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
12. Mai 2022 08:25 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
05. Mai 2022 08:20 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in...
Accelus Launches Ultra-Low-Profile FlareHawk7™ Expandable Cage Implant and Innovative Instruments to Support Endoscopic, MIS Lumbar Fusion Procedures
17. August 2021 10:42 ET
|
Accelus
PALM BEACH GARDENS, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...